Q32 Bio (QTTB) EPS (Basic) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 40.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00% |
| Dec 31, 2025 | 524.32% |
| Sep 30, 2025 | 58.90% |
| Jun 30, 2025 | 45.07% |
| Mar 31, 2025 | -187.38% |
| Dec 31, 2024 | 98.56% |
| Sep 30, 2024 | 96.40% |
| Jun 30, 2024 | 91.49% |
| Mar 31, 2024 | 105.19% |
| Dec 31, 2023 | -12,758.33% |
| Sep 30, 2023 | -6,767.80% |
| Jun 30, 2023 | -3,172.55% |
| Mar 31, 2023 | -1,332.30% |
| Dec 31, 2022 | -1.69% |
| Sep 30, 2022 | -9.26% |
| Jun 30, 2022 | 5.56% |
| Mar 31, 2022 | 8,150.00% |
| Dec 31, 2021 | 3.28% |
| Sep 30, 2021 | 12.90% |
| Jun 30, 2021 | 30.77% |
| Mar 31, 2021 | 97.44% |
| Dec 31, 2020 | -10.91% |
| Sep 30, 2020 | 7.46% |
| Jun 30, 2020 | -27.87% |
| Mar 31, 2020 | -21.88% |
| Dec 31, 2019 | -3.77% |
| Sep 30, 2019 | -76.32% |
| Jun 30, 2019 | -79.41% |
| Mar 31, 2019 | 84.35% |
| Dec 31, 2018 | 88.65% |
| Sep 30, 2018 | 86.33% |
| Jun 30, 2018 | 86.97% |
| Mar 31, 2018 | -46.59% |